Status:
UNKNOWN
To Evaluate the Effect of Reveratrol,Folic Acid, Vitamin D, Vitamin B12 and B6 in Male Infertility
Lead Sponsor:
University Of Perugia
Collaborating Sponsors:
Ester Illiano, MD
Conditions:
Male Infertility
Eligibility:
MALE
18-50 years
Phase:
NA
Brief Summary
The objective of this study is to evaluate the impact of the Genante(TM) on the spermiogram parameters in infertile male patients
Detailed Description
This is a single-centre prospective observational study. Twenty infertile male patients. Inclusion criteria are: Age:18-50 years oligozoospermia: \< 5 million spermatozoa/mL; asthenozoospermia: \< 3...
Eligibility Criteria
Inclusion
- male 18-50 years
- oligozoospermia: \< 5 million spermatozoa/mL;
- asthenozoospermia: \< 32% progressive motile spermatozoa;
- teratozoospermia: \< 4% normal forms.
Exclusion
- azoospermia
- smoke
- use drugs
- use drugs with proven fertility toxicity
- exposition to any environmental or occupational toxic substances
- exposition to radiation or heat
- orchitis secondary to mumps
- sexually transmitted diseases
- history of cryptorchidism
- previous testicular torsion
- genitourinary anomalies
- alterations of the epididymis or deferens
- inguinal surgery
Key Trial Info
Start Date :
January 20 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2019
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03864198
Start Date
January 20 2019
End Date
April 30 2019
Last Update
March 6 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Elisabetta Costantini
Terni, Italy, 05100